Sign in to view content

Randomized, Prospective, Double-Masked, Controlled Phase 2b Trial to Evaluate the Safety and Efficacy of ALG-1001 (Luminate®) in Diabetic Macular Edema

Peter K. Kaiser, MD FASRS

Video
Published 2018

Related

Twelve Month Safety and Efficacy Outcomes from a Phase 2 Study of APL-2 in Patients with Geographic Atrophy
David S. Boyer, MD
Updates from the Field
2017
A Novel Biocompatible Film to Promote Retinals Breaks Repair and Macular Hole Closure
Stanislao Rizzo, MD
Annual Meeting Talks
2018
Intravitreal Aflibercept for Moderately Severe to Severe Non-Proliferative Diabetic Retinopathy (NPDR): The Phase 3 PANORAMA Study
Charles C Wykoff, MD, PhD, FASRS
Annual Meeting Talks
2018

Category: Diabetic Retinopathy

See more